To subscribe to our optical e-newsletters and receive them via e-mail, click here.


Retinal Insider

Real-World Utilization of Anti-VEGF Agents

How ‘real world’ clinical experience with anti-VEGF drugs in treating three FDA-approved indications differs from clinical trial results.

A New Understanding of Vitreous Structure

Advances in imaging technologies are changing both the way we think of the vitreous and how we treat patients.

Shifting Focus in Retinal Implant Development

Moving beyond the proof-of-concept stage, a greater emphasis on the functional outcomes of retinal implants is needed.

Personalized Medicine: Impact on Retina Therapies

The power of genetically defined targets in the development of retinal therapies is beginning to bear fruit. Where it’s headed next.

PVR: An Update on Prevention & Management

We have learned much about the pathogenesis of PVR but have a lot of ground to cover to effectively treat this devastating disease.

Targeting Fas in Retinal Disease

Novel research is exploring protecting photoreceptors and the retinal pigment epithlium in multiple models of retinal disease.

Updated Guidelines for Intravitreal Injection

The protocols for IVT injection continue to evolve as the procedure becomes one of the most-performed in U.S. medicine.

Stem Cell Treatments: What’s Happening in 2015

The use of stem cells to treat retinal disease has moved beyond the theoretical and proof-of-concept stages and into clinical trials.

Anti-VEGF Therapy to Limit DR Progression

Although many questions remain, anti-VEGF therapies for diabetic retinopathy treatment will dramatically alter the delivery of care.

Outer Retinal Layers as Predictors of Vision Loss

Advances in optical coherence tomography reveal correlations between retinal anatomy and vision loss in several retinal diseases.